Additionally, a significantly lower NT-proBNP value was observed in the PAH group compared with the CTEPH one, which maintained elevated NT-proBNP levels at baseline, 6 months, and 12 months, respectively. Here, NPPB is linked to pulmonary arterial hypertension.